{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:45:11Z","timestamp":1793335511995,"version":"4.5.0"},"reference-count":15,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2025,4,1]]},"abstract":"<jats:sec id=\"ab-dbr240027-4\"><jats:title>Importance<\/jats:title><jats:p>A critical need exists for developing a validated dermatologic-specific treatment satisfaction instrument.<\/jats:p><\/jats:sec><jats:sec id=\"ab-dbr240027-5\"><jats:title>Objective<\/jats:title><jats:p>To evaluate the structural validity, internal consistency, construct validity, and test-retest reliability of the 7-item dermatology-specific treatment satisfaction (DermSat-7) instrument in patients with psoriasis.<\/jats:p><\/jats:sec><jats:sec id=\"ab-dbr240027-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This survey study was conducted from July 2020 to April 2023 in dermatology outpatient clinics at the University of Southern California, Brigham and Women\u2019s Hospital, and Mount Sinai Union Square and included adults (aged \u226518 years) with psoriasis who were fluent in English. On day 1, the clinician at the study sites assessed psoriasis disease severity in person using the Psoriasis Area and Severity Index (PASI), body surface area (BSA), and Physician Global Assessment (PGA). On day 1, study participants completed the DermSat-7, the generic 9-item Treatment Satisfaction Questionnaire for Medication (TSQM-9), and the Dermatology Life Quality Index (DLQI). They also answered demographic questions and reported their own disease severity using the Patient Global Assessment (PtGA). On day 14 (\u00b12 days), the patient then completed the DermSat-7 and PtGA a second time.<\/jats:p><\/jats:sec><jats:sec id=\"ab-dbr240027-7\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>The DermSat-7 is a 7-item self-administered instrument with a recall period of 14 days that assesses patient satisfaction with their treatments across various inflammatory dermatology diseases, including psoriasis.  Construct validity, structural validity, internal consistency, and test-retest reliability of DermSat-7 were assessed as defined by the  Consensus-Based Standards for the Selection of Health Measurement Instruments (COSMIN) taxonomy and reported following the COSMIN reporting guideline for studies on measurement properties.<\/jats:p><\/jats:sec><jats:sec id=\"ab-dbr240027-8\"><jats:title>Results<\/jats:title><jats:p>The analysis included 142 patients with psoriasis (mean [SD] age, 51.1 [15.5] years; 77 males [54.2%]). Exploratory factor analysis and confirmatory factor analysis supported the unidimensionality of the DermSat-7 domains. The internal consistency of the effectiveness and convenience domains was high with a Cronbach \u03b1 of 0.88 and 0.81, respectively. Regarding construct validity, differences between groups based on PASI\/PGA scores were aligned with preexisting hypotheses, and the correlations between DermSat-7 and TSQM-9 subscores were strong to very strong (\u03c1\u2009=\u20090.75 for effectiveness; \u03c1\u2009=\u20090.66 for convenience; and \u03c1\u2009=\u20090.70 for overall satisfaction; all <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001). Intraclass correlation was 0.85, indicating high test-retest reliability.<\/jats:p><\/jats:sec><jats:sec id=\"ab-dbr240027-9\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>This survey study found that the DermSat-7 may be  a valid and reliable instrument for measuring treatment satisfaction in patients with psoriasis.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamadermatol.2024.6567","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T16:32:55Z","timestamp":1740587575000},"page":"416","source":"Crossref","is-referenced-by-count":3,"title":["Validation of DermSat-7 for Assessing Treatment Satisfaction in Patients With Psoriasis"],"prefix":"10.1001","volume":"161","author":[{"given":"April W.","family":"Armstrong","sequence":"first","affiliation":[{"name":"Division of Dermatology, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Lee","sequence":"additional","affiliation":[{"name":"St Louis University School of Medicine, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Yee","sequence":"additional","affiliation":[{"name":"Division of Dermatology, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Woodbury","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Zundell","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Zagona-Prizio","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Colorado School of Medicine, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Yousif","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carly","family":"Grant","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Shields","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peichi","family":"Chou","sequence":"additional","affiliation":[{"name":"University of California, Riverside School of Medicine, Riverside"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Callis Duffin","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice B.","family":"Gottlieb","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph F.","family":"Merola","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Department of Medicine, Division of Rheumatology, UT Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Perez-Chada","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"dbr240027r1","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1001\/jamadermatol.2021.2007","article-title":"Psoriasis prevalence in adults in the United States.","volume":"157","author":"Armstrong","year":"2021","journal-title":"JAMA Dermatol"},{"key":"dbr240027r2","doi-asserted-by":"publisher","first-page":"m1590","DOI":"10.1136\/bmj.m1590","article-title":"National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study.","volume":"369","author":"Parisi","year":"2020","journal-title":"BMJ"},{"issue":"19","key":"dbr240027r3","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: a review.","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"dbr240027r4","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.2147\/PPA.S167508","article-title":"Medication adherence and persistence in patients with rheumatoid arthritis, psoriasis, and psoriatic arthritis: a systematic literature review.","volume":"12","author":"Murage","year":"2018","journal-title":"Patient Prefer Adherence"},{"issue":"5-6","key":"dbr240027r5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1159\/000490413","article-title":"Are your patients satisfied a systematic review of treatment satisfaction measures in psoriasis.","volume":"234","author":"Salame","year":"2018","journal-title":"Dermatology"},{"issue":"10","key":"dbr240027r6","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1001\/jamadermatol.2018.1165","article-title":"Identifying a core domain set to assess psoriasis in clinical trials.","volume":"154","author":"Callis Duffin","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"8","key":"dbr240027r7","first-page":"770","article-title":"International Dermatology Outcome Measures (IDEOM) Group 2016 New York meeting: meeting summary and data from the Psoriasis Working Group.","volume":"16","author":"Perez-Chada","year":"2017","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"dbr240027r8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000501582","article-title":"Examination of treatment satisfaction instruments in psoriasis: 2017 results from the psoriasis working group of the International Dermatology Outcome Measures (IDEOM).","volume":"237","author":"Kornmehl","year":"2021","journal-title":"Dermatology"},{"issue":"5","key":"dbr240027r9","doi-asserted-by":"publisher","first-page":"701","DOI":"10.3899\/jrheum.170151","article-title":"Defining outcome measures for psoriasis: The IDEOM Report from the GRAPPA 2016 Annual Meeting.","volume":"44","author":"Callis Duffin","year":"2017","journal-title":"J Rheumatol"},{"issue":"2","key":"dbr240027r10","first-page":"119","article-title":"The International Dermatology Outcome Measures (IDEOM) Initiative: a review and update.","volume":"16","author":"Elman","year":"2017","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"dbr240027r11","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s40257-019-00496-w","article-title":"Investigator and patient global assessment measures for psoriasis clinical trials: a systematic review on measurement properties from the International Dermatology Outcome Measures (IDEOM) initiative.","volume":"21","author":"Perez-Chada","year":"2020","journal-title":"Am J Clin Dermatol"},{"issue":"5","key":"dbr240027r12","doi-asserted-by":"publisher","first-page":"959","DOI":"10.3899\/jrheum.160114","article-title":"International dermatology outcome measures initiative as applied to psoriatic disease outcomes: an update.","volume":"43","author":"Merola","year":"2016","journal-title":"J Rheumatol"},{"issue":"5","key":"dbr240027r13","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s11136-018-1798-3","article-title":"COSMIN guideline for systematic reviews of patient-reported outcome measures.","volume":"27","author":"Prinsen","year":"2018","journal-title":"Qual Life Res"},{"issue":"1","key":"dbr240027r15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1001\/jamadermatol.2023.4481","article-title":"Evaluation of DermSat-7 for assessing treatment satisfaction in patients with acne.","volume":"160","author":"Shields","year":"2024","journal-title":"JAMA Dermatol"},{"key":"dbr240027r14","unstructured":"Mokkink? L, Prinsen? C, Patrick? D, . COSMIN Study Design checklist for patient-reported outcome measurement instruments. Published online July 2019. Accessed January 21, 2025. https:\/\/www.cosmin.nl\/wp-content\/uploads\/COSMIN-study-designing-checklist_final.pdf"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2830419\/jamadermatology_armstrong_2025_br_240027_1744811629.70789.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T15:00:56Z","timestamp":1744815656000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2830419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2024.6567","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,1]]}}}